Bristol-Myers Squibb(us:BMY)

    57.76

    +0.31%

    Updated on 2024-12-25

    Open:57.41
    Close:57.76
    High:57.77
    Low:57.01
    Pre Close:57.58
    Volume:3.67M
    Amount:210.98M
    Turnover:0.18%
    Shares:2.03B
    MarketCap:117.15B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-309559466630.29%72351
    2024-03-312456152001766775.00%1598881168
    2023-12-312576162208454181.18%2486601445
    2023-09-302520161558789277.33%1197641341
    2023-06-302529155938982374.23%1089051184
    2023-03-312548156487237074.40%10010011109
    2022-12-312598159332062376.78%2359801029
    2022-09-302519160557937375.19%879631120
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Vanguard Group Inc1865711579.20%5040480.27%
    2024-06-30Blackrock Inc.1586588537.83%-3902228-2.40%
    2024-06-30State Street Corp914453664.51%-125744-0.14%
    2024-06-30Jpmorgan Chase & Co746299263.68%-14184197-15.97%
    2024-06-30Charles Schwab Investment Management Inc590616742.91%53457089.95%
    2024-06-30Capital International Investors554065922.73%-14797222-21.08%
    2024-06-30Geode Capital Management, Llc421675212.08%8629162.09%
    2024-06-30Fmr Llc406648222.01%-1900380-4.46%
    2024-06-30Norges Bank325944161.61%14291734.59%
    2024-06-30Morgan Stanley261551051.29%-3114505-10.64%

    About

    Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
    Address:Route 206 & Province Line Road

    Market Movers